• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路易体痴呆患者与阿尔茨海默病患者睡眠状况的比较。

A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease.

作者信息

Grace J B, Walker M P, McKeith I G

机构信息

Lecturer in Psychiatry, Department of Old Age Psychiatry, Wolfson Research Unit, Newcastle General Hospital, Newcastle upon Tyne, UK.

出版信息

Int J Geriatr Psychiatry. 2000 Nov;15(11):1028-33. doi: 10.1002/1099-1166(200011)15:11<1028::aid-gps227>3.0.co;2-e.

DOI:10.1002/1099-1166(200011)15:11<1028::aid-gps227>3.0.co;2-e
PMID:11113983
Abstract

INTRODUCTION

Sleep disturbances are common in healthy old age and in dementia syndromes. Polysomnography has demonstrated typical changes in both Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) with AD being characterised by sundowning and sleep apnoea and DLB patients showing more disturbances of movement control during sleep. The technical difficulties associated with EEG sleep recordings mean that polysomnography is not possible out of specialist centres.

OBJECTIVES

To use questionnaires to assess the frequency of sleep disturbances in patients with Alzheimer's disease and dementia with Lewy bodies.

METHOD

The sleep profiles of twenty patients with AD and 17 with DLB were assessed using three questionnaires, one designed to assess night time sleep disturbance, one day time sleepiness and the last carer burden. The sleep questionnaires were repeated in a subgroup after treatment with a cholinesterase inhibitor (rivastigmine).

RESULTS

Level of sleep disturbance in both groups was high. DLB patients had more overall sleep disturbance, more movement disorders whilst asleep and more abnormal day time sleepiness. Treatment with rivastigmine produced a trend towards normalisation of sleep profile in a small number of subjects.

CONCLUSIONS

Both groups have extensive sleep problems. The DLB and AD groups have different sleep profiles that are of diagnostic importance and may suggest different treatment strategies. The results are consistent with those found from polysomnographic assessment and suggest that the questionnaires used are sensitive to detect differences previously documented with polysomnography.

摘要

引言

睡眠障碍在健康老年人和痴呆综合征中很常见。多导睡眠图已证实阿尔茨海默病(AD)和路易体痴呆(DLB)均有典型变化,AD的特征为日落综合征和睡眠呼吸暂停,而DLB患者在睡眠期间表现出更多运动控制障碍。与脑电图睡眠记录相关的技术难题意味着在专科中心以外无法进行多导睡眠图检查。

目的

使用问卷评估阿尔茨海默病和路易体痴呆患者睡眠障碍的发生率。

方法

使用三份问卷评估20例AD患者和17例DLB患者的睡眠状况,一份用于评估夜间睡眠障碍,一份用于评估日间嗜睡,最后一份用于评估照料者负担。在一组患者接受胆碱酯酶抑制剂(卡巴拉汀)治疗后重复进行睡眠问卷调查。

结果

两组的睡眠障碍程度都很高。DLB患者总体睡眠障碍更多,睡眠时运动障碍更多,日间异常嗜睡更多。卡巴拉汀治疗使少数受试者的睡眠状况有趋于正常化的趋势。

结论

两组均存在广泛的睡眠问题。DLB组和AD组有不同的睡眠状况,具有诊断意义,可能提示不同的治疗策略。结果与多导睡眠图评估结果一致,表明所使用的问卷对于检测先前多导睡眠图记录的差异很敏感。

相似文献

1
A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease.路易体痴呆患者与阿尔茨海默病患者睡眠状况的比较。
Int J Geriatr Psychiatry. 2000 Nov;15(11):1028-33. doi: 10.1002/1099-1166(200011)15:11<1028::aid-gps227>3.0.co;2-e.
2
Cholinesterase inhibitors for dementia with Lewy bodies.用于路易体痴呆的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2003;2003(3):CD003672. doi: 10.1002/14651858.CD003672.
3
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study.与阿尔茨海默病相比,路易体痴呆患者对卡巴拉汀的认知和精神病理反应:一项病例对照研究。
Am J Alzheimers Dis Other Demen. 2007 Feb-Mar;22(1):42-7. doi: 10.1177/1533317506297517.
4
Higher Frequency and Complexity of Sleep Disturbances in Dementia with Lewy Bodies as Compared to Alzheimer's Disease.与阿尔茨海默病相比,路易体痴呆患者睡眠障碍的频率更高且更复杂。
Neurodegener Dis. 2016;16(3-4):152-60. doi: 10.1159/000439252. Epub 2015 Nov 10.
5
Pharmacologic treatment expectations in the management of dementia with Lewy bodies.路易体痴呆管理中的药物治疗期望
Dement Geriatr Cogn Disord. 2004;17 Suppl 1:32-9. doi: 10.1159/000074680.
6
Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.用卡巴拉汀治疗路易体痴呆:对认知、神经精神症状及睡眠的影响
Int Psychogeriatr. 2001 Sep;13(3):277-88. doi: 10.1017/s1041610201007670.
7
Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.卡巴拉汀治疗路易体痴呆:一项开放试验的初步结果。
Int J Geriatr Psychiatry. 2000 May;15(5):387-92. doi: 10.1002/(sici)1099-1166(200005)15:5<387::aid-gps131>3.0.co;2-9.
8
Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.长期使用卡巴拉汀治疗路易体痴呆患者:一项开放标签试验。
Int Psychogeriatr. 2001 Jun;13(2):199-205. doi: 10.1017/s104161020100758x.
9
Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease.卡巴拉汀对阿尔茨海默病痴呆患者行为和心理症状的影响。
Clin Ther. 2004 Jul;26(7):980-90. doi: 10.1016/s0149-2918(04)90172-5.
10
EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.对早期阿尔茨海默病、路易体痴呆和帕金森病痴呆患者进行脑电图比较,并随访2年。
Brain. 2008 Mar;131(Pt 3):690-705. doi: 10.1093/brain/awm322. Epub 2008 Jan 17.

引用本文的文献

1
Protocol for a scoping review of measurement of sleep in mild cognitive impairment and early dementia.轻度认知障碍和早期痴呆症中睡眠测量的范围综述方案
AMRC Open Res. 2021 Apr 14;3:13. doi: 10.12688/amrcopenres.12981.1. eCollection 2021.
2
Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults.认知未受损成年人睡眠与阿尔茨海默病生物标志物的横断面及纵向关联
Brain Commun. 2022 Nov 3;4(6):fcac257. doi: 10.1093/braincomms/fcac257. eCollection 2022.
3
Sleep disturbances in Lewy body dementia: A systematic review.
路易体痴呆中的睡眠障碍:系统评价。
Int J Geriatr Psychiatry. 2022 Oct;37(10). doi: 10.1002/gps.5814.
4
The past, present, and future of sleep measurement in mild cognitive impairment and early dementia-towards a core outcome set: a scoping review.轻度认知障碍和早期痴呆症中睡眠测量的过去、现在和未来——迈向核心结局集:范围综述。
Sleep. 2022 Jul 11;45(7). doi: 10.1093/sleep/zsac077.
5
Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.失眠和睡眠障碍负担以及可能或可能患有阿尔茨海默病患者的睡眠治疗的影响:一项结构化文献回顾。
J Alzheimers Dis. 2022;86(1):83-109. doi: 10.3233/JAD-215324.
6
THE ENIGMA OF LEWY BODY DEMENTIA: A CASE REPORT.路易体痴呆之谜:一例报告。
Acta Clin Croat. 2020 Dec;59(4):771-776. doi: 10.20471/acc.2020.59.04.27.
7
Sleep-Based Interventions in Alzheimer's Disease: Promising Approaches from Prevention to Treatment along the Disease Trajectory.阿尔茨海默病中基于睡眠的干预措施:沿着疾病轨迹从预防到治疗的有前景的方法。
Pharmaceuticals (Basel). 2021 Apr 19;14(4):383. doi: 10.3390/ph14040383.
8
Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration.tau 蛋白相关神经退行性疾病模型中的脑电功率、睡眠周期和行为的纵向变化。
Alzheimers Res Ther. 2020 Jul 15;12(1):84. doi: 10.1186/s13195-020-00651-0.
9
Impaired Hippocampal-Cortical Interactions during Sleep in a Mouse Model of Alzheimer's Disease.阿尔茨海默病小鼠模型睡眠期间海马-皮质相互作用受损。
Curr Biol. 2020 Jul 6;30(13):2588-2601.e5. doi: 10.1016/j.cub.2020.04.087. Epub 2020 May 28.
10
Use of Cholinesterase Inhibitors in Non-Alzheimer's Dementias.在非阿尔茨海默病痴呆中使用胆碱酯酶抑制剂。
Drugs Aging. 2019 Aug;36(8):719-731. doi: 10.1007/s40266-019-00685-6.